96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection. (Q53819119)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | 96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection. |
scientific article |
Statements
96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection. (English)
Patrick Marcellin
Maria Buti
Kosh Agarwal
Maurizia Brunetto
Young-Suk Lim
Scott Fung
Wan-Long Chuang
Ho Bae
Manoj Sharma
Harry L A Janssen
Calvin Q Pan
Mustafa Kemal Çelen
Norihiro Furusyo
Ki Tae Yoon
Huy Trinh
John F Flaherty
Anuj Gaggar
Audrey H Lau
Lanjia Lin
Neeru Bhardwaj
Vithika Suri
G Mani Subramanian
Edward J Gane
Henry L Y Chan
GS-US-320-0110
GS-US-320-0108 Investigators
17 January 2018